vs

Side-by-side financial comparison of Evolus, Inc. (EOLS) and FLOTEK INDUSTRIES INC (FTK). Click either name above to swap in a different company.

Evolus, Inc. is the larger business by last-quarter revenue ($73.1M vs $70.1M, roughly 1.0× FLOTEK INDUSTRIES INC). FLOTEK INDUSTRIES INC runs the higher net margin — 6.7% vs -14.6%, a 21.3% gap on every dollar of revenue. On growth, FLOTEK INDUSTRIES INC posted the faster year-over-year revenue change (27.0% vs 6.7%). Over the past eight quarters, FLOTEK INDUSTRIES INC's revenue compounded faster (23.2% CAGR vs 4.6%).

Evolus, Inc. is a medical aesthetics company focused on developing and commercializing non-surgical cosmetic treatment solutions. Its flagship product is a prescription neuromodulator designed to reduce moderate to severe glabellar frown lines, serving licensed aesthetic healthcare providers and consumers across North America, Europe, and key Asia-Pacific regional markets.

Flotek Industries Inc. is a technology-driven diversified company that develops and supplies specialty chemicals, performance materials and related equipment solutions for global energy, mining and industrial manufacturing sectors, delivering innovative sustainable products to boost client operational efficiency.

EOLS vs FTK — Head-to-Head

Bigger by revenue
EOLS
EOLS
1.0× larger
EOLS
$73.1M
$70.1M
FTK
Growing faster (revenue YoY)
FTK
FTK
+20.3% gap
FTK
27.0%
6.7%
EOLS
Higher net margin
FTK
FTK
21.3% more per $
FTK
6.7%
-14.6%
EOLS
Faster 2-yr revenue CAGR
FTK
FTK
Annualised
FTK
23.2%
4.6%
EOLS

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
EOLS
EOLS
FTK
FTK
Revenue
$73.1M
$70.1M
Net Profit
$-10.7M
$4.7M
Gross Margin
66.9%
22.2%
Operating Margin
23.8%
10.8%
Net Margin
-14.6%
6.7%
Revenue YoY
6.7%
27.0%
Net Profit YoY
EPS (diluted)
$-0.16
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EOLS
EOLS
FTK
FTK
Q1 26
$73.1M
$70.1M
Q4 25
$90.3M
$67.5M
Q3 25
$69.0M
$56.0M
Q2 25
$69.4M
$58.4M
Q1 25
$68.5M
$55.4M
Q4 24
$78.9M
$50.8M
Q3 24
$61.1M
$49.7M
Q2 24
$66.9M
$46.2M
Net Profit
EOLS
EOLS
FTK
FTK
Q1 26
$-10.7M
$4.7M
Q4 25
$130.0K
$3.0M
Q3 25
$-15.7M
$20.4M
Q2 25
$-17.1M
$1.8M
Q1 25
$-18.9M
$5.4M
Q4 24
$-6.8M
$4.4M
Q3 24
$-19.2M
$2.5M
Q2 24
$-11.3M
$2.0M
Gross Margin
EOLS
EOLS
FTK
FTK
Q1 26
66.9%
22.2%
Q4 25
65.7%
22.5%
Q3 25
66.5%
31.7%
Q2 25
65.3%
24.7%
Q1 25
68.1%
22.5%
Q4 24
66.7%
24.2%
Q3 24
68.9%
18.3%
Q2 24
70.3%
19.9%
Operating Margin
EOLS
EOLS
FTK
FTK
Q1 26
23.8%
10.8%
Q4 25
4.7%
8.9%
Q3 25
-16.7%
16.2%
Q2 25
-14.7%
4.4%
Q1 25
-22.1%
10.1%
Q4 24
-2.9%
10.1%
Q3 24
-25.3%
5.5%
Q2 24
-11.5%
4.8%
Net Margin
EOLS
EOLS
FTK
FTK
Q1 26
-14.6%
6.7%
Q4 25
0.1%
4.5%
Q3 25
-22.8%
36.3%
Q2 25
-24.7%
3.0%
Q1 25
-27.6%
9.7%
Q4 24
-8.6%
8.7%
Q3 24
-31.4%
5.1%
Q2 24
-17.0%
4.3%
EPS (diluted)
EOLS
EOLS
FTK
FTK
Q1 26
$-0.16
$0.12
Q4 25
$0.01
$0.09
Q3 25
$-0.24
$0.53
Q2 25
$-0.27
$0.05
Q1 25
$-0.30
$0.17
Q4 24
$-0.11
$0.15
Q3 24
$-0.30
$0.08
Q2 24
$-0.18
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EOLS
EOLS
FTK
FTK
Cash + ST InvestmentsLiquidity on hand
$49.8M
$5.7M
Total DebtLower is stronger
$156.4M
Stockholders' EquityBook value
$118.2M
Total Assets
$220.6M
$231.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EOLS
EOLS
FTK
FTK
Q1 26
$49.8M
$5.7M
Q4 25
$53.8M
$5.7M
Q3 25
$43.5M
$4.6M
Q2 25
$61.7M
$5.0M
Q1 25
$67.9M
$6.3M
Q4 24
$87.0M
$4.4M
Q3 24
$85.0M
$5.0M
Q2 24
$93.7M
$4.8M
Total Debt
EOLS
EOLS
FTK
FTK
Q1 26
$156.4M
Q4 25
$146.1M
$40.0M
Q3 25
$40.0M
Q2 25
$40.0M
Q1 25
$121.8M
Q4 24
$121.5M
Q3 24
$121.2M
Q2 24
$120.9M
Stockholders' Equity
EOLS
EOLS
FTK
FTK
Q1 26
$118.2M
Q4 25
$-23.1M
$113.1M
Q3 25
$-28.8M
$110.5M
Q2 25
$-18.7M
$71.8M
Q1 25
$-6.6M
$119.7M
Q4 24
$5.5M
$113.9M
Q3 24
$5.9M
$109.0M
Q2 24
$19.3M
$106.2M
Total Assets
EOLS
EOLS
FTK
FTK
Q1 26
$220.6M
$231.8M
Q4 25
$225.9M
$220.0M
Q3 25
$219.0M
$212.7M
Q2 25
$228.8M
$172.2M
Q1 25
$213.4M
$170.2M
Q4 24
$232.6M
$170.8M
Q3 24
$229.6M
$160.6M
Q2 24
$233.8M
$156.0M
Debt / Equity
EOLS
EOLS
FTK
FTK
Q1 26
Q4 25
0.35×
Q3 25
0.36×
Q2 25
0.56×
Q1 25
Q4 24
22.00×
Q3 24
20.58×
Q2 24
6.26×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EOLS
EOLS
FTK
FTK
Operating Cash FlowLast quarter
$21.0K
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
0.00×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EOLS
EOLS
FTK
FTK
Q1 26
$21.0K
Q4 25
$12.8M
$6.2M
Q3 25
$-14.7M
$-1.9M
Q2 25
$-24.8M
$-4.5M
Q1 25
$-15.6M
$7.3M
Q4 24
$4.8M
$-2.6M
Q3 24
$-5.7M
$5.1M
Q2 24
$-6.5M
$-3.1M
Free Cash Flow
EOLS
EOLS
FTK
FTK
Q1 26
Q4 25
$11.3M
Q3 25
$-15.6M
Q2 25
$-25.5M
Q1 25
$-16.0M
Q4 24
$4.4M
Q3 24
$-6.0M
Q2 24
$-6.9M
FCF Margin
EOLS
EOLS
FTK
FTK
Q1 26
Q4 25
12.6%
Q3 25
-22.7%
Q2 25
-36.7%
Q1 25
-23.3%
Q4 24
5.5%
Q3 24
-9.9%
Q2 24
-10.4%
Capex Intensity
EOLS
EOLS
FTK
FTK
Q1 26
1.4%
Q4 25
1.6%
Q3 25
1.4%
Q2 25
1.0%
Q1 25
0.5%
Q4 24
0.6%
Q3 24
0.5%
Q2 24
0.7%
Cash Conversion
EOLS
EOLS
FTK
FTK
Q1 26
0.00×
Q4 25
98.67×
2.07×
Q3 25
-0.09×
Q2 25
-2.54×
Q1 25
1.36×
Q4 24
-0.58×
Q3 24
2.01×
Q2 24
-1.55×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EOLS
EOLS

Product revenue, net$72.7M99%
Service revenue$390.0K1%

FTK
FTK

Revenue from related party$51.9M74%
Revenue from external customers$18.2M26%

Related Comparisons